$9M Shaved From Novartis Jaw Injury Award By NY Judge

Law360, New York (October 11, 2013, 6:37 PM ET) -- A New York judge on Wednesday denied Novartis Pharmaceuticals Corp.’s bid for a mistrial declaration in litigation over jaw deterioration injuries purportedly linked to bone drug Zometa, but slashed a $10 million punitive damage award to just less than $1 million.

U.S. District Court Judge Arthur Spatt rejected Novartis's argument that a juror had improperly relied on external information in reaching the damage award in a November 2012 plaintiff's verdict by consulting the dictionary for a definition of the word “wanton,” saying those allegations are based on...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers